BioCentury
ARTICLE | Company News

BioHelix Corp., Qiagen deal

May 5, 2008 7:00 AM UTC

Qiagen received a worldwide, non-exclusive license to use BioHelix's Helicase Dependent Amplification (HDA) assay technology. HDA is used to detect and analyze biological target molecules such as DNA ...